Archives

AlphaSense Raises $350 Million At $7.5 Billion Valuation While Surpassing $600 Million In Annual Recurring Revenue

By Amit Chowdhry ● Jun 7, 2026

AlphaSense announced a $350 million funding round that values the AI-powered market intelligence platform at $7.5 billion, nearly doubling its previous $4 billion valuation and bringing total funding raised to more than $1 billion.

Cense Raises €6.5 Million Seed Round To Expand Digital Asset Compliance Platform Across Europe

By Amit Chowdhry ● Jun 7, 2026

Cense announced a €6.5 million seed funding round co-led by Giesecke+Devrient Ventures and Rabo Investments, with additional participation from several angel investors.

Shifters Raises $10.2 Million Seed Round To Advance AI-Native Autonomous Ground Robotics

By Amit Chowdhry ● Jun 7, 2026

Shifters, a technology company developing AI-native autonomous robotic teams, announced a $10.2 million seed funding round led by Ace Capital Partners, bringing the company’s total funding to $15 million.

Offroad Raises $7 Million To Build An AI-Powered Identity Security Team

By Amit Chowdhry ● Jun 7, 2026

Offroad, a startup focused on identity security automation, emerged from stealth with $7 million in seed funding led by Ibex Investors and Skywell Capital Partners. The company is developing an AI-powered identity security platform designed to investigate and remediate risks across human identities, machine identities, OAuth applications, service accounts, and AI agents.

Sriram Krishnan To Leave White House AI Advisory Role After Helping Shape U.S. AI Strategy

By Amit Chowdhry ● Jun 7, 2026

Sriram Krishnan announced that he will leave his role as Senior Policy Advisor for Artificial Intelligence at the White House at the end of June, concluding an 18-month tenure during which he played a key role in shaping the administration’s AI policy agenda.

Novo Nordisk: Wegovy Pill Surpasses 3 Million Prescriptions In Five Months As Obesity Treatment Adoption Accelerates

By Amit Chowdhry ● Jun 7, 2026

Novo Nordisk announced that Wegovy (semaglutide) tablets 25 mg have surpassed 3 million prescriptions in the United States since launching on January 5, 2026, marking one of the strongest pharmaceutical product launches by prescription volume in recent U.S. history.

Kingsley And Company Expands Commercial Real Estate Access Through Community-Focused Development In Cincinnati

By Amit Chowdhry ● Jun 7, 2026

Kingsley and Company, a minority-owned commercial real estate investment and development firm based in Cincinnati, is expanding its efforts to increase access to commercial real estate and support community development through a combination of affordable housing, mixed-use projects, and neighborhood revitalization initiatives.

New Dawn Bio Raises €2.1 Million Pre-Seed Round To Commercialize Cultured Wood

By Amit Chowdhry ● Jun 7, 2026

New Dawn Bio announced an oversubscribed €2.1 million pre-seed funding round to advance the development and commercialization of cultured wood, a technology designed to produce wood without harvesting trees.

Backcast Partners Makes Follow-On Investment In Guardian Fleet Services To Support Expansion Strategy

By Amit Chowdhry ● Jun 7, 2026

Backcast Partners announced a follow-on investment in Guardian Fleet Services, a leading provider of commercial towing, recovery, and specialized transportation services across the United States.

Ona Therapeutics Raises $86.6 Million Series B To Advance First-In-Class ADC Cancer Programs

By Amit Chowdhry ● Jun 7, 2026

Ona Therapeutics, a biopharmaceutical company developing antibody-drug conjugates (ADCs) for treatment-resistant cancers, announced the close of an oversubscribed $86.6 million Series B financing to support the advancement of its oncology pipeline into clinical development.

Collate Raises $95 Million Series A To Expand AI Platform For Regulated Life Sciences Workflows

By Amit Chowdhry ● Jun 7, 2026

Collate announced a $95 million Series A funding round as the company continues building an AI-native platform designed for regulated workflows across the life sciences industry. The round was led by a group of investors that includes Redpoint Ventures, First Round Capital, CRV, Conviction, and Y Combinator. The company said the funding will support its mission of delivering trusted, patient-first artificial intelligence solutions for pharmaceutical and life sciences organizations.

RadX Receives Investment From Kain Capital To Expand Outpatient Radiology Platform

By Amit Chowdhry ● Jun 7, 2026

Kain Capital announced the completion of its investment in RadX Inc., an outpatient radiology platform operating a network of 26 independent imaging centers across Florida, Michigan, Maryland, Georgia, Tennessee, and Alabama. The investment is intended to support RadX’s continued expansion across high-growth and underserved markets as demand for outpatient diagnostic imaging services continues to increase.